Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)
China flag China · Delayed Price · Currency is CNY
9.09
+0.12 (1.34%)
Sep 30, 2026, 3:00 PM CST

Tibet Weixinkang Medicine Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
278.73212.22216.44269.43519.32243.77
Trading Asset Securities
786.15770803625.32287467.78
Cash & Short-Term Investments
1,065982.221,019894.75806.32711.55
Cash Growth
3.52%-3.65%13.94%10.97%13.32%23.64%
Accounts Receivable
155.09134.87172.29179.77222.85193.13
Other Receivables
2.22.171.932.22.141.22
Receivables
157.29137.04174.22181.96224.99194.35
Inventory
63.4459.8241.9638.3432.5422.68
Prepaid Expenses
-0.072.621.731.682.14
Other Current Assets
103.38109.7777.1483.1273.4378.44
Total Current Assets
1,3891,2891,3151,2001,1391,009
Property, Plant & Equipment
410.59416.46380.25361.21333.73324.14
Long-Term Investments
70.4374.9569.0575.8871.3362.49
Other Intangible Assets
20.6723.2916.5935.3924.412.83
Long-Term Deferred Tax Assets
25.4728.8842.9256.2130.189.75
Long-Term Deferred Charges
38.6515.7316.9126.3641.5273.35
Other Long-Term Assets
9.8518.6312.5921.9325.293.85
Total Assets
1,9651,8671,8541,7771,6651,496

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
6.59.315.481.473.50.85
Accrued Expenses
270.77255.69314.28269.95284.17271.98
Current Portion of Leases
6.483.972.893.862.312.47
Current Income Taxes Payable
11.332.060.663.836.784.3
Current Unearned Revenue
1.586.397.244.46.547.75
Other Current Liabilities
87.0870.8996.63111.27108.5131.92
Total Current Liabilities
383.73348.31427.18394.79411.8419.26
Long-Term Leases
4.577.232.383.823.482.35
Long-Term Unearned Revenue
5.524.177.053.845.256.7
Pension & Post-Retirement Benefits
20.3220.2728.86---
Long-Term Deferred Tax Liabilities
9.7110.52.783.461.17-
Other Long-Term Liabilities
---30.6423.14-
Total Liabilities
423.85390.49468.24436.55444.84428.31

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
435.16435.16435.16435.16435.16435.92
Additional Paid-In Capital
347.64347.64347.64347.15341.35318.64
Retained Earnings
787.87722.76631.28579.63453.82346.51
Treasury Stock
-30-30-30-22.37-23.8-52.88
Comprehensive Income & Other
0.130.81.360.7814.0519.07
Total Common Equity
1,5411,4761,3851,3401,2211,067
Shareholders' Equity
1,5411,4761,3851,3401,2211,067
Total Liabilities & Equity
1,9651,8671,8541,7771,6651,496

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
11.0511.25.277.685.794.81
Net Cash (Debt)
1,054971.021,014887.07800.53706.73
Net Cash Growth
2.78%-4.25%14.33%10.81%13.27%22.80%
Net Cash Per Share
2.452.252.352.071.851.69
Filing Date Shares Outstanding
432.33432.33432.33435.16435.16435.92
Total Common Shares Outstanding
432.33432.33432.33435.16435.16435.92
Working Capital
1,005940.6888.19805.12727.17589.9
Book Value Per Share
3.563.413.203.082.802.45
Tangible Book Value
1,5201,4531,3691,3051,1961,054
Tangible Book Value Per Share
3.523.363.173.002.752.42
Buildings
328.81328.89285.16280.15260.92258.81
Machinery
358.5339.93297.15274.57236.19215.29
Construction In Progress
18.2521.4537.9815.1917.11-